The store will not work correctly when cookies are disabled.
We are currently experiencing a delay in order processing for some digital products. Our team is actively working to resolve this issue. To avoid placing duplicate orders, please do not refresh or move away from the payment screen during checkout. If your order still shows a status of 'Processing' after 24 - 48 hours, please contact customer support.
We are currently experiencing a delay in order processing for some digital products. Our team is actively working to resolve this issue. To avoid placing duplicate orders, please do not refresh or move away from the payment screen during checkout. If your order still shows a status of 'Processing' after 24 - 48 hours, please contact customer support.
Alert
We are currently experiencing a delay in order processing for some digital products. Our team is actively working to resolve this issue. To avoid placing duplicate orders, please do not refresh or move away from the payment screen during checkout. If your order still shows a status of 'Processing' after 24 - 48 hours, please contact customer support.
Participation in activities of daily life can be challenging for those with transthyretin amyloid cardiomyopathy (ATTR-CM), a restrictive cardiomyopathy produced by extracellular deposition of transthyretin. Geographic and racial healthcare disparities add to the burden of disease. Shared decision making and early detection with readily available noninvasive tests, among other strategies, are essential as therapy for ATTR-CM.
